Posts Tagged ‘Surgery’
Anew Optics
Anna Hayes describes Anew Optics lens design program with the specific objective of removing or managing significantly post-cataract surgery patient health issues including instability of refractive correction, capsular opacification & posterior segment events. Presenter: Anna Hayes Anna S. Hayes, CEO founded Anew Optics, Inc. and has guided the Company since its inception, managing the full…
Read More2014 Ophthalmology Innovator Award Presentation
Gil Kliman presents the 2014 Ophthalmology Innovator Award to Mark Forchette, President & CEO of OptiMedica. OptiMedica, with Mark at the helm, is leading the way to developing a entire new market in ophthalmology for femtosecond lasers. Listen to Gil interview Mark on how he got to where he is today. Presenter: Gilbert H. Kliman,…
Read MoreLarge Device Companies Eyeing Opportunities in Ophthalmic Space
NEW ORLEANS — The oft-repeated Cajun expression in this fun loving town, ”laissez les bon temps roulez,” translated as let the good times roll may be an accurate way of summarizing the upbeat mood at this year’s annual meeting of the American Academy of Ophthalmology (AAO; San Francisco). The AAO is by far the largest…
Read MoreVC Says There Are Many ‘Unmet Needs’ in Ophthalmology Space
SAN FRANCISCO — The second annual Ophthalmology Innovation Summit (OIS) was held in conjunction with the American Society of Cataract and Refractive Surgeons (ASCRS; Reston, Virginia). International Business Forum (Massapequa, New York) organized the meeting. The purpose of the OIS conference is to support innovation by facilitating deal-flow and business partnerships between CEOs of young…
Read MoreOIS Sets Sights on Anterior Segment Innovations
The second annual Ophthalmology Innovation Summit (OIS) at the 2013 ASCRS•ASOA Symposium & Congress combined industry, clinicians, and entrepreneurs to highlight innovations in anterior segment surgery. The half-day session featured talks on the impact of femtosecond lasers and intraoperative aberrometry, as well as micro-invasive glaucoma surgery (MIGS). Co-chairman William J. Link, PhD, Versant Ventures, Menlo…
Read MoreAll Eyes on Ophthalmic Innovation: An Interview with Bill Link
The ophthalmology drug, device and medical technology sector is poised for continued growth, as innovators and entrepreneurs unblinkingly stare down the ongoing domino effect being caused by an aging population, which begets a proliferation in eye disease incidence, which, in turn, begets an unprecedented patient base that consequently requires the types of novel ophthalmic products…
Read More